Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer

N. Takigawa, Katsuyuki Kiura, Y. Segawa, Y. Watanabe, H. Kamei, T. Moritaka, T. Shibayama, H. Ueoka, K. Gemba, T. Yonei, Masahiro Tabata, T. Shinkai, S. Hiraki, M. Takemoto, Susumu Kanazawa, K. Matsuo, M. Tanimoto

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Long-term cancer survivors risk development of second primary cancers (SPC). Vigilant follow-up may be required. We report outcomes of 92 patients who underwent chemoradiation for unresectable stage III non-small-cell lung cancer, with a median follow-up of 8.9 years. The incidence of SPC was 2.4 per 100 patient-years (95% confidence interval: 1.0-4.9).

Original languageEnglish
Pages (from-to)1142-1144
Number of pages3
JournalBritish Journal of Cancer
Volume95
Issue number9
DOIs
Publication statusPublished - Nov 6 2006

Fingerprint

Second Primary Neoplasms
Non-Small Cell Lung Carcinoma
Survivors
Confidence Intervals
Incidence
Neoplasms

Keywords

  • Chemotherapy
  • Non-small-cell lung cancer
  • Radiotherapy
  • Second primary cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer. / Takigawa, N.; Kiura, Katsuyuki; Segawa, Y.; Watanabe, Y.; Kamei, H.; Moritaka, T.; Shibayama, T.; Ueoka, H.; Gemba, K.; Yonei, T.; Tabata, Masahiro; Shinkai, T.; Hiraki, S.; Takemoto, M.; Kanazawa, Susumu; Matsuo, K.; Tanimoto, M.

In: British Journal of Cancer, Vol. 95, No. 9, 06.11.2006, p. 1142-1144.

Research output: Contribution to journalArticle

Takigawa, N, Kiura, K, Segawa, Y, Watanabe, Y, Kamei, H, Moritaka, T, Shibayama, T, Ueoka, H, Gemba, K, Yonei, T, Tabata, M, Shinkai, T, Hiraki, S, Takemoto, M, Kanazawa, S, Matsuo, K & Tanimoto, M 2006, 'Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer', British Journal of Cancer, vol. 95, no. 9, pp. 1142-1144. https://doi.org/10.1038/sj.bjc.6603422
Takigawa, N. ; Kiura, Katsuyuki ; Segawa, Y. ; Watanabe, Y. ; Kamei, H. ; Moritaka, T. ; Shibayama, T. ; Ueoka, H. ; Gemba, K. ; Yonei, T. ; Tabata, Masahiro ; Shinkai, T. ; Hiraki, S. ; Takemoto, M. ; Kanazawa, Susumu ; Matsuo, K. ; Tanimoto, M. / Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer. In: British Journal of Cancer. 2006 ; Vol. 95, No. 9. pp. 1142-1144.
@article{1b196259db83414c8def48e0cc0fe249,
title = "Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer",
abstract = "Long-term cancer survivors risk development of second primary cancers (SPC). Vigilant follow-up may be required. We report outcomes of 92 patients who underwent chemoradiation for unresectable stage III non-small-cell lung cancer, with a median follow-up of 8.9 years. The incidence of SPC was 2.4 per 100 patient-years (95{\%} confidence interval: 1.0-4.9).",
keywords = "Chemotherapy, Non-small-cell lung cancer, Radiotherapy, Second primary cancer",
author = "N. Takigawa and Katsuyuki Kiura and Y. Segawa and Y. Watanabe and H. Kamei and T. Moritaka and T. Shibayama and H. Ueoka and K. Gemba and T. Yonei and Masahiro Tabata and T. Shinkai and S. Hiraki and M. Takemoto and Susumu Kanazawa and K. Matsuo and M. Tanimoto",
year = "2006",
month = "11",
day = "6",
doi = "10.1038/sj.bjc.6603422",
language = "English",
volume = "95",
pages = "1142--1144",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer

AU - Takigawa, N.

AU - Kiura, Katsuyuki

AU - Segawa, Y.

AU - Watanabe, Y.

AU - Kamei, H.

AU - Moritaka, T.

AU - Shibayama, T.

AU - Ueoka, H.

AU - Gemba, K.

AU - Yonei, T.

AU - Tabata, Masahiro

AU - Shinkai, T.

AU - Hiraki, S.

AU - Takemoto, M.

AU - Kanazawa, Susumu

AU - Matsuo, K.

AU - Tanimoto, M.

PY - 2006/11/6

Y1 - 2006/11/6

N2 - Long-term cancer survivors risk development of second primary cancers (SPC). Vigilant follow-up may be required. We report outcomes of 92 patients who underwent chemoradiation for unresectable stage III non-small-cell lung cancer, with a median follow-up of 8.9 years. The incidence of SPC was 2.4 per 100 patient-years (95% confidence interval: 1.0-4.9).

AB - Long-term cancer survivors risk development of second primary cancers (SPC). Vigilant follow-up may be required. We report outcomes of 92 patients who underwent chemoradiation for unresectable stage III non-small-cell lung cancer, with a median follow-up of 8.9 years. The incidence of SPC was 2.4 per 100 patient-years (95% confidence interval: 1.0-4.9).

KW - Chemotherapy

KW - Non-small-cell lung cancer

KW - Radiotherapy

KW - Second primary cancer

UR - http://www.scopus.com/inward/record.url?scp=33750482212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750482212&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6603422

DO - 10.1038/sj.bjc.6603422

M3 - Article

C2 - 17031394

AN - SCOPUS:33750482212

VL - 95

SP - 1142

EP - 1144

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 9

ER -